BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38009602)

  • 1. Exploring the role of lactylation-related genes in osteosarcoma: A deep dive into prognostic significance and therapeutic potential.
    Sun J; Li Y; Chen R; Xie Y; Wei J; Li B
    Environ Toxicol; 2024 Feb; 39(2):1001-1017. PubMed ID: 38009602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructing lactylation-related genes prognostic model to effectively predict the disease-free survival and treatment responsiveness in prostate cancer based on machine learning.
    Pan J; Zhang J; Lin J; Cai Y; Zhao Z
    Front Genet; 2024; 15():1343140. PubMed ID: 38566813
    [No Abstract]   [Full Text] [Related]  

  • 3. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc.
    Shen S; Yao T; Xu Y; Zhang D; Fan S; Ma J
    Mol Cancer; 2020 Oct; 19(1):151. PubMed ID: 33106166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
    Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
    EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
    Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
    Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
    Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
    J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
    Zhang X; Wen Z; Wang Q; Ren L; Zhao S
    Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
    Chen J; Guo X; Zeng G; Liu J; Zhao B
    Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma.
    Huang W; Xiao Y; Wang H; Chen G; Li K
    Front Endocrinol (Lausanne); 2022; 13():1047433. PubMed ID: 36387908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2.
    Wang L; Hu K; Chao Y; Wang X
    J Cell Biochem; 2020 Feb; 121(2):2038-2046. PubMed ID: 31633240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization.
    Sheng G; Gao Y; Ding Q; Zhang R; Wang T; Jing S; Zhao H; Ma T; Wu H; Yang Y
    J Transl Med; 2023 Feb; 21(1):132. PubMed ID: 36803784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma.
    Mao X; Song F; Jin J; Zou B; Dai P; Sun M; Xu W; Wang L; Kang Y
    Front Immunol; 2023; 14():1202725. PubMed ID: 37465666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma.
    Feng J; Wang J; Xu Y; Lu F; Zhang J; Han X; Zhang C; Wang G
    PLoS One; 2023; 18(7):e0288180. PubMed ID: 37405988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
    Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel MYC target gene set signature for predicting the prognosis of osteosarcoma patients.
    Gong D; Zhao Q; Liu J; Zhao S; Yi C; Lv J; Yu H; Bian E; Tian D
    Front Oncol; 2023; 13():1169430. PubMed ID: 37342196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.